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Background
Abnormal bleeding has been reported with several antide-
pressants especially SSRIs. Only 25 cases have been
reported in the literature, covering a spectrum from
abnormal subclinical laboratory findings to ecchymoses
and bleeding. Althought there are theories concerning the
etiopathogenic mechanisms, data are inconclusive.
Material and Methods
We report a case of ecchymosis leading to treatment dis-
continuation following fluoxetine use. The case con-
cerned a 28 years old female patient suffering from DSM-
IV major depression.
Results
She was not receiving any medication during the previous
6 months. She was started on fluoxetine 20 mg daily and
after three weeks the dose raise to 40 mg. After about a
week and while the patient started responding to treat-
ment, she manifested 7 ecchymoses in the inner surface of
both thighs. All laboratory investigation including blood
and biochemical testing, liver and renal function, pro-
thrombin time, partial prothrombin time and bleeding
time were normal. This was in accord with the literature.
She was changed to sertraline (gradually up to 200 mg
daily). Depressive symptoms resolved within the next four
weeks. About one and a half month after fluoxetine dis-
continuation and still under sertraline treatment ecchy-
moses gradually disappeared. From the history of the
patient, it is clear that there was a temporal relationship
between ecchymoses and fluoxetine treatment.
Discussion
Although ecchymoses is a benign adverse effect of antide-
pressant therapy, it is important for the clinician to be
alert, since its relationship to other life-threatening blood-
related adverse effect is unknown
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